Reference Listed Drug Selection

Reference Listed Drug Selection is the regulatory decision-making process in bioequivalence regulation whereby a competent authority designates a specific previously approved drug product as the reference listed drug that serves as the legal and scientific benchmark for establishing pharmaceutical equivalence and bioequivalence of proposed generic products.

3

Publications

50

Citations

19

Authors

14

Institutions

Publications per year

2017–2026

1

Authors

19

  1. CD
    Carolina de Lima Rossi

    McMaster University, Canada

    1 publications · 11 citations

    1

    h-index

  2. LL
    László Lorenzovici

    Institute for Health Metrics and Evaluation, United States

    1 publications · 27 citations

    1

    h-index

  3. GG
    Gordon Guyatt

    McMaster University, Canada

    1 publications · 11 citations

    1

    h-index

  4. SB
    Sílvio Barberato-Filho

    Universidade de Sorocaba, Brazil

    1 publications · 11 citations

    1

    h-index

  5. MM
    Manoela Manova

    Medical University of Sofia, Bulgaria

    1 publications · 27 citations

    1

    h-index

1–5 of 19

Venues

  1. Health Policy and Technology

    1 publications · 27 citations

    1

    h-index

  2. BMC Public Health

    1 publications · 11 citations

    1

    h-index

  3. PubMed

    Repository · 1 publications · 12 citations

    1

    h-index

1–3